NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice
Xianfei Wang, Kangyue Sun, Youlian Zhou, Hong Wang, Yongjian Zhou, Side Liu, Yuqiang Nie, Yue Li
Topics & Concepts
SteatosisInflammasomeChemistryFatty liverInternal medicinePharmacologyBiochemistryMedicineReceptorDiseaseLiver Disease Diagnosis and TreatmentInflammasome and immune disordersFatty Acid Research and Health